Sage Therapeutics Inc (SAGE) — Free Cash Flow Generation Index

Latest as of December 2020: 1.00x

Sage Therapeutics Inc (SAGE) has a Free Cash Flow Generation Index of 1.00x as of December 2020. Free cash flow of $1.01 Billion represents 1% of operating cash flow ($1.01 Billion). See Sage Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

$1.01 Billion

USD

Operating Cash Flow

$1.01 Billion

USD

Capital Expenditures

$1.00K

USD

Sage Therapeutics Inc Free Cash Flow Generation Index (2020–2020)

Historical FCF Generation Index trend for Sage Therapeutics Inc across 1 annual periods. Explore Sage Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Sage Therapeutics Inc (2020–2020)

Year-by-year Free Cash Flow Generation Index for Sage Therapeutics Inc. For the full company profile including market capitalisation, see Sage Therapeutics Inc (SAGE) market capitalisation.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2020	1.00x	$663.93 Million	$664.28 Million	$345.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).